BridgeMD
New treatment option for Parkinson Disease
Official title Innovative Models in the Rehabilitation of the Elderly With Parkinson's Disease Through Technological Innovation
ClinicalTrials.gov ID: NCT04087031
What this study is testing
- What it's testing
- The final goal of the present study is to propose a new approach in the Parkinson's Disease rehabilitation, focused on the use of robotic devices and to check the results not only at the end of the treatment but also in the long term, foreseeing 3 follow-up.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Hoen and Yahr scale: 1-3 stage
- FAC ≤ 2
- Ranking scale score ≤ 3
- Stability of drug treatment for at least 1 month
- Geriatric Depression Scale 5-items: negative
You likely can't join if
- Concomitant participation in other studies
- Lack of written informed consent
- Clinical dementia rating (CDR) score ≥ 3
- History of syncopal episodes, epilepsy and vertigo not controlled pharmacologically
- Serious dysfunction of the autonomic system
- Severe behavioral syndromes not compensated by drugs
See the full eligibility criteria
- Hoen and Yahr scale: 1-3 stage
- FAC ≤ 2
- Ranking scale score ≤ 3
- Stability of drug treatment for at least 1 month
- Geriatric Depression Scale 5-items: negative
- Concomitant participation in other studies
- Lack of written informed consent
- Clinical dementia rating (CDR) score ≥ 3
- History of syncopal episodes, epilepsy and vertigo not controlled pharmacologically
- Serious dysfunction of the autonomic system
- Severe behavioral syndromes not compensated by drugs
- Concurrent neurological diseases
- Severe systemic diseases with life expectancy \< 1 year
- Patients unable to follow up.
The study team makes the final eligibility decision.
Where it's taking place
- Ancona, Italy
- Fermo, Italy
Compensation & support
A stipend or compensation may be offered.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ancona, Italy; Fermo, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.